Andrew Galler
Stock Analyst at Morgan Stanley
(0.50)
# 3,795
Out of 4,789 analysts
29
Total ratings
27.78%
Success rate
-15.89%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrew Galler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Assumes: Equal-Weight | $35 | $29.67 | +17.96% | 13 | Mar 7, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Equal-Weight | $14 → $15 | $8.16 | +83.82% | 5 | Nov 9, 2023 | |
| SLN Silence Therapeutics | Initiates: Equal-Weight | $18 | $2.82 | +538.30% | 1 | Dec 9, 2022 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Equal-Weight | $41 → $37 | $12.74 | +190.42% | 2 | Nov 29, 2022 | |
| IONS Ionis Pharmaceuticals | Maintains: Overweight | $57 → $56 | $30.17 | +85.61% | 2 | Nov 10, 2022 | |
| VIR Vir Biotechnology | Maintains: Underweight | $15 → $18 | $6.48 | +177.78% | 2 | Nov 4, 2022 | |
| PTCT PTC Therapeutics | Initiates: Equal-Weight | $54 | $50.96 | +5.97% | 1 | Sep 9, 2022 | |
| HALO Halozyme Therapeutics | Initiates: Overweight | $50 | $63.81 | -21.64% | 1 | Sep 9, 2022 | |
| ADCT ADC Therapeutics | Initiates: Outperform | $44 | $1.41 | +3,020.57% | 1 | Nov 9, 2021 | |
| MRNA Moderna | Initiates: Outperform | $304 | $28.35 | +972.31% | 1 | Nov 9, 2021 |
Immunocore Holdings
Mar 7, 2025
Assumes: Equal-Weight
Price Target: $35
Current: $29.67
Upside: +17.96%
Amicus Therapeutics
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $8.16
Upside: +83.82%
Silence Therapeutics
Dec 9, 2022
Initiates: Equal-Weight
Price Target: $18
Current: $2.82
Upside: +538.30%
Arrowhead Pharmaceuticals
Nov 29, 2022
Maintains: Equal-Weight
Price Target: $41 → $37
Current: $12.74
Upside: +190.42%
Ionis Pharmaceuticals
Nov 10, 2022
Maintains: Overweight
Price Target: $57 → $56
Current: $30.17
Upside: +85.61%
Vir Biotechnology
Nov 4, 2022
Maintains: Underweight
Price Target: $15 → $18
Current: $6.48
Upside: +177.78%
PTC Therapeutics
Sep 9, 2022
Initiates: Equal-Weight
Price Target: $54
Current: $50.96
Upside: +5.97%
Halozyme Therapeutics
Sep 9, 2022
Initiates: Overweight
Price Target: $50
Current: $63.81
Upside: -21.64%
ADC Therapeutics
Nov 9, 2021
Initiates: Outperform
Price Target: $44
Current: $1.41
Upside: +3,020.57%
Moderna
Nov 9, 2021
Initiates: Outperform
Price Target: $304
Current: $28.35
Upside: +972.31%